Search Results - "Berry, Lindsay"

Bayesian Forecasting of Many Count-Valued Time Series by Berry, Lindsay R., West, Mike

“…We develop and exemplify application of new classes of dynamic models for time series of nonnegative counts. Our novel univariate models combine dynamic…”
Get full text

Ventilator Weaning Strategies—Managing Interaction Between Randomized Treatments by Webb, Steven A, Berry, Lindsay R, Serpa Neto, Ary

Get full text

Probabilistic forecasting of heterogeneous consumer transaction–sales time series by Berry, Lindsay R., Helman, Paul, West, Mike

“…We present new Bayesian methodology for consumer sales forecasting. Focusing on the multi-step-ahead forecasting of daily sales of many supermarket items, we…”
Get full text

Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis by Godolphin, Peter J, Fisher, David J, Berry, Lindsay R, Derde, Lennie P G, Diaz, Janet V, Gordon, Anthony C, Lorenzi, Elizabeth, Marshall, John C, Murthy, Srinivas, Shankar-Hari, Manu, Sterne, Jonathan A C, Tierney, Jayne F, Vale, Claire L

“…A recent prospective meta-analysis demonstrated that interleukin-6 antagonists are associated with lower all-cause mortality in hospitalised patients with…”
Get full text

Optimal sample size division in two-stage seamless designs by Berry, Lindsay R, Marion, Joe, Berry, Scott M, Viele, Kert

“…Inferentially seamless 2/3 designs are increasingly popular in clinical trials. It is important to understand their relative advantages compared with separate…”
Get full text

Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19 by Goligher, Ewan C, Lawler, Patrick R, Jensen, Thomas P, Talisa, Victor, Berry, Lindsay R, Lorenzi, Elizabeth, McVerry, Bryan J, Chang, Chung-Chou Ho, Leifer, Eric, Bradbury, Charlotte, Berger, Jeffrey, Hunt, Beverly J, Castellucci, Lana A, Kornblith, Lucy Z, Gordon, Anthony C, McArthur, Colin, Webb, Steven, Hochman, Judith, Neal, Matthew D, Zarychanski, Ryan, Berry, Scott, Angus, Derek C

“…IMPORTANCE: Randomized clinical trials (RCTs) of therapeutic-dose heparin in patients hospitalized with COVID-19 produced conflicting results, possibly due to…”
Get full text

REMAP Periop: a randomised, embedded, multifactorial adaptive platform trial protocol for perioperative medicine to determine the optimal enhanced recovery pathway components in complex abdominal surgery patients within a US healthcare system by Holder-Murray, Jennifer, Esper, Stephen A, Althans, Alison R, Knight, Joshua, Subramaniam, Kathirvel, Derenzo, Joseph, Ball, Ryan, Beaman, Shawn, Luke, Charles, La Colla, Luca, Schott, Nicholas, Williams, Brian, Lorenzi, Elizabeth, Berry, Lindsay R, Viele, Kert, Berry, Scott, Masters, Miranda, Meister, Katie A, Wilkinson, Todd, Garrard, William, Marroquin, Oscar C, Mahajan, Aman

“…IntroductionImplementation of enhanced recovery pathways (ERPs) has resulted in improved patient-centred outcomes and decreased costs. However, there is a lack…”
Get full text

Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analyses by Bruce, Pepa, Ainscough, Kate, Hatter, Lee, Braithwaite, Irene, Berry, Lindsay R, Fitzgerald, Mark, Hills, Thomas, Brickell, Kathy, Cosgrave, David, Semprini, Alex, Morpeth, Susan, Berry, Scott, Doran, Peter, Young, Paul, Beasley, Richard, Nichol, Alistair

“…Coronavirus disease 2019 (COVID-19) has exposed the disproportionate effects of pandemics on frontline workers and the ethical imperative to provide effective…”
Get full text

Correction: Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analyses by Bruce, Pepa, Ainscough, Kate, Hatter, Lee, Braithwaite, Irene, Berry, Lindsay R, Fitzgerald, Mark, Hills, Thomas, Brickell, Kathy, Cosgrave, David, Semprini, Alex, Morpeth, Susan, Berry, Scott, Doran, Peter, Young, Paul, Beasley, Richard, Nichol, Alistair

Get full text

Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19 by McCreary, Erin K, Bariola, J Ryan, Wadas, Richard J, Shovel, Judith A, Wisniewski, Mary Kay, Adam, Michelle, Albin, Debbie, Minnier, Tami, Schmidhofer, Mark, Meyers, Russell, Marroquin, Oscar C, Collins, Kevin, Garrard, William, Berry, Lindsay R, Berry, Scott, Crawford, Amy M, McGlothlin, Anna, Linstrum, Kelsey, Nakayama, Anna, Montgomery, Stephanie K, Snyder, Graham M, Yealy, Donald M, Angus, Derek C, Kip, Paula L, Seymour, Christopher W, Huang, David T, Kip, Kevin E

“…Monoclonal antibody (mAb) treatment decreases hospitalization and death in high-risk outpatients with mild to moderate COVID-19; however, only intravenous…”
Get full text

Inactivation of the STT7 gene protects PsaF-deficient Chlamydomonas reinhardtii cells from oxidative stress under high light by Berry, Lindsay L, Brzezowski, Pawel, Wilson, Kenneth E

“…Photosystem I (PSI) utilizes light energy to excite electrons for the reduction of NADP⁺, and like photosystem II, it is sensitive to excess light. When PSI is…”
Get full text

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 by Mégarbane, Bruno

Get full text

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 AMeta-analysis by Shankar-Hari, M, Vale, CL, Godolphin, PJ, Fisher, D, Higgins, JPT, Spiga, F, Savovic, J, Tierney, J, Baron, G, Benbenishty, JS

Get full text

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 by Gordon, Anthony C, Mouncey, Paul R, Al-Beidh, Farah, Rowan, Kathryn M, Nichol, Alistair D, Arabi, Yaseen M, Annane, Djillali, Beane, Abi, van Bentum-Puijk, Wilma, Berry, Lindsay R, Bhimani, Zahra, Bonten, Marc J M, Bradbury, Charlotte A, Brunkhorst, Frank M, Buzgau, Adrian, Cheng, Allen C, Detry, Michelle A, Duffy, Eamon J, Estcourt, Lise J, Fitzgerald, Mark, Goossens, Herman, Haniffa, Rashan, Higgins, Alisa M, Hills, Thomas E, Horvat, Christopher M, Lamontagne, Francois, Lawler, Patrick R, Leavis, Helen L, Linstrum, Kelsey M, Litton, Edward, Lorenzi, Elizabeth, Marshall, John C, Mayr, Florian B, McAuley, Daniel F, McGlothlin, Anna, McGuinness, Shay P, McVerry, Bryan J, Montgomery, Stephanie K, Morpeth, Susan C, Murthy, Srinivas, Orr, Katrina, Parke, Rachael L, Parker, Jane C, Patanwala, Asad E, Pettilä, Ville, Rademaker, Emma, Santos, Marlene S, Saunders, Christina T, Seymour, Christopher W, Shankar-Hari, Manu, Sligl, Wendy I, Turgeon, Alexis F, Turner, Anne M, van de Veerdonk, Frank L, Zarychanski, Ryan, Green, Cameron, Lewis, Roger J, Angus, Derek C, McArthur, Colin J, Berry, Scott, Webb, Steve A, Derde, Lennie P G

“…The interleukin-6 receptor blockers tocilizumab and sarilumab were tested against standard care in a randomized trial involving patients newly admitted to the…”
Get full text

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial by Higgins, Alisa M, Berry, Lindsay R, Lorenzi, Elizabeth, Murthy, Srinivas, McQuilten, Zoe, Mouncey, Paul R, Al-Beidh, Farah, Annane, Djillali, Arabi, Yaseen M, Beane, Abi, van Bentum-Puijk, Wilma, Bhimani, Zahra, Bonten, Marc J. M, Bradbury, Charlotte A, Brunkhorst, Frank M, Burrell, Aiden, Buzgau, Adrian, Buxton, Meredith, Charles, Walton N, Cove, Matthew, Detry, Michelle A, Estcourt, Lise J, Fagbodun, Elizabeth O, Fitzgerald, Mark, Girard, Timothy D, Goligher, Ewan C, Goossens, Herman, Haniffa, Rashan, Hills, Thomas, Horvat, Christopher M, Huang, David T, Ichihara, Nao, Lamontagne, Francois, Marshall, John C, McAuley, Daniel F, McGlothlin, Anna, McGuinness, Shay P, McVerry, Bryan J, Neal, Matthew D, Nichol, Alistair D, Parke, Rachael L, Parker, Jane C, Parry-Billings, Karen, Peters, Sam E. C, Reyes, Luis F, Rowan, Kathryn M, Saito, Hiroki, Santos, Marlene S, Saunders, Christina T, Serpa-Neto, Ary, Seymour, Christopher W, Shankar-Hari, Manu, Stronach, Lucy M, Turgeon, Alexis F, Turner, Anne M, van de Veerdonk, Frank L, Zarychanski, Ryan, Green, Cameron, Lewis, Roger J, Angus, Derek C, McArthur, Colin J, Berry, Scott, Derde, Lennie P. G, Gordon, Anthony C, Webb, Steve A, Lawler, Patrick R

“…IMPORTANCE: The longer-term effects of therapies for the treatment of critically ill patients with COVID-19 are unknown. OBJECTIVE: To determine the effect of…”
Get full text

Pathologic response in resectable non-small cell lung cancer: a systematic literature review and meta-analysis by Waser, Nathalie A, Quintana, Melanie, Schweikert, Bernd, Chaft, Jamie E, Berry, Lindsay, Adam, Ahmed, Vo, Lien, Penrod, John R, Fiore, Joseph, Berry, Donald A, Goring, Sarah

“…Surrogate endpoints for overall survival (OS) in patients with resectable non-small cell lung cancer (NSCLC) receiving neoadjuvant therapy are needed to…”
Get full text

Pathological response in resectable non–small cell lung cancer: a systematic literature review and meta-analysis by Waser, Nathalie A, Quintana, Melanie, Schweikert, Bernd, Chaft, Jamie E, Berry, Lindsay, Adam, Ahmed, Vo, Lien, Penrod, John R, Fiore, Joseph, Berry, Donald A, Goring, Sarah

“…Abstract Background Surrogate endpoints for overall survival in patients with resectable non–small cell lung cancer receiving neoadjuvant therapy are needed to…”
Get full text

Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial by Huang, David T, McCreary, Erin K, Bariola, J Ryan, Minnier, Tami E, Wadas, Richard J, Shovel, Judith A, Albin, Debbie, Marroquin, Oscar C, Kip, Kevin E, Collins, Kevin, Schmidhofer, Mark, Wisniewski, Mary Kay, Nace, David A, Sullivan, Colleen, Axe, Meredith, Meyers, Russell, Weissman, Alexandra, Garrard, William, Peck-Palmer, Octavia M, Wells, Alan, Bart, Robert D, Yang, Anne, Berry, Lindsay R, Berry, Scott, Crawford, Amy M, McGlothlin, Anna, Khadem, Tina, Linstrum, Kelsey, Montgomery, Stephanie K, Ricketts, Daniel, Kennedy, Jason N, Pidro, Caroline J, Nakayama, Anna, Zapf, Rachel L, Kip, Paula L, Haidar, Ghady, Snyder, Graham M, McVerry, Bryan J, Yealy, Donald M, Angus, Derek C, Seymour, Christopher W

“…The effectiveness of monoclonal antibodies (mAbs), casirivimab-imdevimab and sotrovimab, is unknown in patients with mild to moderate COVID-19 caused by the…”
Get full text

The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization by Huang, David T, McCreary, Erin K, Bariola, J Ryan, Wadas, Richard J, Kip, Kevin E, Marroquin, Oscar C, Koscumb, Stephen, Collins, Kevin, Shovel, Judith A, Schmidhofer, Mark, Wisniewski, Mary Kay, Sullivan, Colleen, Yealy, Donald M, Axe, Meredith, Nace, David A, Haidar, Ghady, Khadem, Tina, Linstrum, Kelsey, Snyder, Graham M, Seymour, Christopher W, Montgomery, Stephanie K, McVerry, Bryan J, Berry, Lindsay, Berry, Scott, Meyers, Russell, Weissman, Alexandra, Peck-Palmer, Octavia M, Wells, Alan, Bart, Robert, Albin, Debbie L, Minnier, Tami, Angus, Derek C

“…The primary objective is to evaluate the comparative effectiveness of COVID-19 specific monoclonal antibodies (mABs) with US Food and Drug Administration (FDA)…”
Get full text

The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial by McCreary, Erin K., Bariola, J. Ryan, Minnier, Tami E., Wadas, Richard J., Shovel, Judith A., Albin, Debbie, Marroquin, Oscar C., Kip, Kevin E., Collins, Kevin, Schmidhofer, Mark, Wisniewski, Mary Kay, Nace, David A., Sullivan, Colleen, Axe, Meredith, Meyers, Russell, Weissman, Alexandra, Garrard, William, Peck-Palmer, Octavia M., Wells, Alan, Bart, Robert D., Yang, Anne, Berry, Lindsay R., Berry, Scott, Crawford, Amy M., McGlothlin, Anna, Khadem, Tina, Linstrum, Kelsey, Montgomery, Stephanie K., Ricketts, Daniel, Kennedy, Jason N., Pidro, Caroline J., Haidar, Ghady, Snyder, Graham M., McVerry, Bryan J., Yealy, Donald M., Angus, Derek C., Nakayama, Anna, Zapf, Rachel L., Kip, Paula L., Seymour, Christopher W., Huang, David T.

“…Monoclonal antibodies (mAb) that neutralize SARS-CoV-2 decrease hospitalization and death compared to placebo in patients with mild to moderate COVID-19;…”
Get full text